Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03569085Phase 1Completed
Phase 1, open-label trial of sevoflurane and isoflurane. Primary endpoint: Global longitudinal strain. Started Jun 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03569085.